Publisher
Springer Science and Business Media LLC
Reference245 articles.
1. Centers for Disease Control and Prevention. National Diabetes Statistical Report. Centers for Disease Control and Prevention https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf (2020).
2. Koye, D. N., Magliano, D. J., Nelson, R. G. & Pavkov, M. E. The global epidemiology of diabetes and kidney disease. Adv. Chronic Kidney Dis. 25, 121–132 (2018).
3. Gregg, E. W. et al. Changes in diabetes-related complications in the United States, 1990–2010. N. Engl. J. Med. 370, 1514–1523 (2014). Unlike the prevalence of other diabetic microvascular and macrovascular complications, which have decreased over the past 10–20 years, the prevalence of DKD has remained unchanged.
4. Lytvyn, Y., Bjornstad, P., van Raalte, D. H., Heerspink, H. L. & Cherney, D. Z. I. The new biology of diabetic kidney disease-mechanisms and therapeutic implications. Endocr. Rev. 41, 202–231 (2020). An excellent review of therapies for DKD currently in use or in clinical development.
5. Zinman, B. et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373, 2117–2128 (2015).
Cited by
235 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献